Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Moleac a biopharmaceutical company based in Singapore announced the approval by the US Food and Drug Administration FDA of an investigational new drug IND application for MLC in traumatic brain injury TBI Moleac is dedicated in finding developing and...
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of cancer metabolic autoimmune and other major diseases and AnHeart Therapeutics Co Ltd AnHeart a clin...
CStone Pharmaceuticals a leading biopharmaceutical company focused on researching developing and commercializing innovative immunooncology therapies and precision medicines today announced that a registrational clinical trial GEMSTONE study of the an...
Biohaven Pharmaceutical Holding Company Ltd today announced that the US Food and Drug Administration FDA has approved NURTEC ODT rimegepant mg for the preventive treatment of migraine NURTEC ODT is indicated for adult patients with episodic migraine...
Dynavax Technologies Corporation a biopharmaceutical company focused on developing and commercializing novel vaccines today announced it has entered into a commercialization agreement with Bavarian Nordic for the marketing and distribution of HEPLISA...
ProBioGen and Minapharm Pharmaceuticals announce the incorporation of ProBioGens subsidiary MiGenTra with headquarters in Berlin and access to a site in Cairo which will house its principal manufacturing plant The formation of MiGenTra accelerates Pr...
TransThera Biosciences Co Ltd TransThera a clinical stage biotechnology company dedicated to developing innovative therapeutics across oncology cardiovascular and inflammatory diseases with major unmet medical needs globally and in China today ann...
Foresee Pharmaceuticals announced today that the US Food and Drug Administration FDA has approved the New Drug Application NDA for CAMCEVI mg a readytouse month subcutaneous depot formulation of leuprolide mesylate as a treatment of advanced prostat...
BlueRock Therapeutics LP a leading engineered cell therapy company and a whollyowned and independently operated subsidiary of Bayer AG and Senti Biosciences Inc Senti Bio a leading gene circuit company today announced a collaboration and option agree...
For the second time in a row Vetter a global leading contract development and manufacturing organization CDMO has won the Axia Best Managed Companies Award The pharmaceutical service provider was again honored for its clear vision innovative approach...
